The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...

Shattered, a bare, tumultuous memoir of the first year of Kureishi’s new life, published in the United Kingdom in October ...

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity. The dramatic ...

J Gastroenterol Hepatol. 2007;22(9):1360-1368. Our study has several limitations. The most important limitation is that the comparative studies we included in our review were not randomized ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Last week a patient came to see me looking very unwell. Having just come out of hospital after her first attack of diverticulitis, she was understandably anxious to learn how to ward off further ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.